MeSH term
Frequency | Condition_Probility | Humans | 49 | 0.0 |
Polymorphism, Genetic/*genetics | 2 | 0.0 |
Animals | 6 | 0.0 |
Male | 14 | 0.0 |
Research Support, Non-U.S. Gov't | 26 | 0.0 |
Sensitivity and Specificity | 4 | 0.0 |
Cell Division/drug effects | 4 | 0.0 |
Cells, Cultured | 5 | 0.0 |
Dose-Response Relationship, Drug | 4 | 0.0 |
Procollagen/biosynthesis | 2 | 28.0 |
Adolescent | 4 | 0.0 |
Adult | 13 | 0.0 |
Comparative Study | 8 | 0.0 |
Aged | 9 | 0.0 |
*Apolipoproteins | 4 | 12.0 |
Female | 19 | 0.0 |
*Glycoproteins | 3 | 0.0 |
Immunohistochemistry | 3 | 0.0 |
In Situ Hybridization | 2 | 0.0 |
*Membrane Transport Proteins | 4 | 0.0 |
Middle Aged | 12 | 0.0 |
Survival Analysis | 2 | 0.0 |
Wound Healing/drug effects | 2 | 6.0 |
Biopsy | 2 | 0.0 |
Collagen/metabolism | 2 | 0.0 |
Losartan/therapeutic use | 2 | 40.0 |
Peptide Fragments/*blood | 4 | 4.0 |
Predictive Value of Tests | 3 | 0.0 |
Procollagen/*blood | 4 | 25.0 |
Treatment Outcome | 2 | 0.0 |
Base Sequence | 2 | 0.0 |
Lymph Nodes/metabolism | 2 | 3.0 |
Lymphatic Metastasis/genetics | 2 | 7.0 |
Molecular Sequence Data | 4 | 0.0 |
Prognosis | 4 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 5 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 2 | 0.0 |
Collagen/*biosynthesis | 2 | 5.0 |
Time Factors | 2 | 0.0 |
Echocardiography | 2 | 0.0 |
Microbial Sensitivity Tests | 2 | 0.0 |
Protein Binding | 4 | 0.0 |
Prevalence | 2 | 0.0 |
Prospective Studies | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 13 | 0.0 |
Axilla | 2 | 3.0 |
Neoplasm Staging | 2 | 0.0 |
Circular Dichroism | 2 | 0.0 |
Mutagenesis, Site-Directed | 2 | 0.0 |
Breast Neoplasms/*pathology | 2 | 0.0 |
Amino Acid Sequence | 3 | 0.0 |
Gene Expression Regulation | 2 | 0.0 |
Cloning, Molecular | 2 | 0.0 |
Blotting, Northern | 2 | 0.0 |
Neoplasm Proteins/*genetics | 2 | 0.0 |
Carrier Proteins/*genetics | 2 | 0.0 |
Actins/*metabolism | 2 | 0.0 |
Calcium-Binding Proteins/*metabolism | 2 | 2.0 |
Gelsolin | 2 | 20.0 |
Microfilament Proteins/*metabolism | 2 | 3.0 |
Phosphatidylinositols/*metabolism | 6 | 7.0 |
Polymers | 2 | 1.0 |
RNA, Messenger/metabolism | 2 | 0.0 |
Phosphorylation | 2 | 0.0 |
Tetradecanoylphorbol Acetate/pharmacology | 2 | 0.0 |
Chromatography, High Pressure Liquid | 3 | 0.0 |
Kinetics | 3 | 0.0 |
Phospholipase C/*blood | 2 | 40.0 |
Erythrocytes/*metabolism | 2 | 0.0 |
Phosphatidylinositol Phosphates | 3 | 37.0 |
Calcium/pharmacology | 3 | 1.0 |
Hydrolysis | 2 | 0.0 |
Phospholipase C/metabolism | 2 | 0.0 |
Phosphatidylinositol 4,5-Diphosphate | 3 | 18.0 |
English Abstract | 2 | 0.0 |
Mice | 2 | 0.0 |
Models, Molecular | 2 | 0.0 |
Protein Structure, Tertiary | 2 | 0.0 |